Rebuilding trust between women and the health care system is critical to address the root causes that have led us where we ...

While it remains to be seen what specific proposals the House and Senate will coalesce around, any changes to the Medicaid ...

Health Affairs' Rob Lott interviews Thomas Buchmueller of the University of Michigan to discuss his recent paper that ...

The potential of biotech-powered consumer health is as sensitive as it is expansive. When it comes to consumer education, ...

For the many young adults living with diabetes, health insurance coverage transitions are not only stressful; they can also ...

The new guidance builds on previous years’ by increasing the focus on transparency and expanding, per statute, to include ...

Conflicting QSSD definitions from two federal agencies mean that CMS’ administrative authority on drug pricing and payment is ...

The Centers for Medicare and Medicaid Services (CMS) proposed new limits on how states use provider taxes to finance their ...

To address the demand-side of this fight, a prevention and treatment-based approach is necessary, as state officials can ...

Policymakers, researchers, community leaders, and advocates must continue their efforts to improve maternal health, including perinatal mental health, under the new administration.

Delaying Medicare’s ability to negotiate prices on small-molecule drugs until 13 years after FDA approval will decrease the ...

Now is the time for policy makers, payers, health systems, and clinicians to act decisively by extending AHCaH, evaluating ...